Ratings changes for Checkpoint Therapeutics, SoundHound AI, Five9, Affirm, Privia Health Group, CrowdStrike, Microchip Technology and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
This Revolutionary Biotech is Advancing Through Clinical Trials (ad)
A young company may be priced like a start-up, but they’re making big strides. With Phase 2 clinical trials completed and regulatory approval for phase 2b/phase 3 clinical trials, their cutting-edge technology could position them as a biotech disruptor. Now’s your chance to learn more about this rising star.
Amazon.com (NASDAQ:AMZN) had its price target raised by analysts at Jefferies Financial Group Inc. () from $235.00 to $275.00. They now have a “buy” rating on the stock. This represents a 18.8% upside from the current price of $231.50.
Amazon.com (NASDAQ:AMZN) had its “market outperform” rating reaffirmed by analysts at JMP Securities (). They now have a $285.00 price target on the stock. This represents a 23.1% upside from the current price of $231.50.
Alphabet Inc. (NASDAQ:GOOGL) announced a quarterly dividend on Monday, October 28th. Stockholders of record on Monday, December 9th will be paid a dividend of 0.20 per share by the information services provider on Monday, December 16th. This represents a $0.80 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend is Monday, December 9th.
Director John L. Hennessy sold 1,500 shares of Alphabet stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $194.22, for a total value of $291,330.00. Following the completion of the transaction, the director now owns 23,324 shares in the company, valued at approximately $4,529,987.28. The trade was a 6.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Meta Platforms, Inc. (NASDAQ:META) declared a quarterly dividend on Thursday, December 5th. Shareholders of record on Monday, December 16th will be paid a dividend of 0.50 per share by the social networking company on Friday, December 27th. This represents a $2.00 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Monday, December 16th.
Advanced Energy Industries (NASDAQ:AEIS) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $140.00 price target on the stock. This represents a 16.3% upside from the current price of $120.41.
Ambarella (NASDAQ:AMBA) was upgraded by analysts at Bank of America Co. from an “underperform” rating to a “neutral” rating. They now have a $80.00 price target on the stock. This represents a 6.5% upside from the current price of $75.15.
AMETEK (NYSE:AME) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $225.00 price target on the stock, up previously from $195.00. This represents a 18.1% upside from the current price of $190.58.
Banco BBVA Argentina (NYSE:BBAR) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “overweight” rating. They now have a $27.00 price target on the stock. This represents a 37.1% upside from the current price of $19.69.
Banco Macro (NYSE:BMA) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “overweight” rating. They now have a $12.50 price target on the stock. This represents a 88.3% downside from the current price of $107.14.
Bristol-Myers Squibb (NYSE:BMY) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $70.00 price target on the stock, up previously from $63.00. This represents a 23.8% upside from the current price of $56.52.
Peabody Energy (NYSE:BTU) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $26.00 price target on the stock. This represents a 18.8% upside from the current price of $21.89.
CBRE Group (NYSE:CBRE) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $163.00 price target on the stock, up previously from $120.00. This represents a 17.1% upside from the current price of $139.20.
Concentra Group Holdings Parent (NYSE:CON) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $24.00 price target on the stock. This represents a 14.0% upside from the current price of $21.06.
ConocoPhillips (NYSE:COP) was upgraded by analysts at Mizuho from a “neutral” rating to an “outperform” rating. They now have a $134.00 price target on the stock, up previously from $132.00. This represents a 32.7% upside from the current price of $101.00.
Comstock Resources (NYSE:CRK) was upgraded by analysts at Mizuho from an “underperform” rating to a “neutral” rating. They now have a $18.00 price target on the stock, up previously from $10.00. This represents a 8.8% upside from the current price of $16.55.
Denali Therapeutics (NASDAQ:DNLI) was upgraded by analysts at Stifel Nicolaus from a “hold” rating to a “buy” rating. They now have a $37.00 price target on the stock. This represents a 59.6% upside from the current price of $23.19.
Equifax (NYSE:EFX) was upgraded by analysts at BNP Paribas from a “neutral” rating to an “outperform” rating. They now have a $305.00 price target on the stock. This represents a 13.0% upside from the current price of $269.83.
EQT (NYSE:EQT) was upgraded by analysts at Mizuho from a “neutral” rating to an “outperform” rating. They now have a $57.00 price target on the stock, up previously from $48.00. This represents a 25.7% upside from the current price of $45.36.
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $90.00 price target on the stock, up previously from $82.00. This represents a 21.6% upside from the current price of $74.00.
Grupo Financiero Galicia (NASDAQ:GGAL) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “overweight” rating. They now have a $92.00 price target on the stock. This represents a 35.1% upside from the current price of $68.10.
Keysight Technologies (NYSE:KEYS) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $200.00 price target on the stock, up previously from $170.00. This represents a 16.5% upside from the current price of $171.68.
LifeStance Health Group (NASDAQ:LFST) was upgraded by analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “buy” rating. They now have a $10.00 price target on the stock. This represents a 31.4% upside from the current price of $7.61.
Macy’s (NYSE:M) was upgraded by analysts at Gordon Haskett from a “hold” rating to a “buy” rating. They now have a $20.00 price target on the stock. This represents a 17.7% upside from the current price of $16.99.
NetApp (NASDAQ:NTAP) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $160.00 price target on the stock. This represents a 27.5% upside from the current price of $125.46.
Okta (NASDAQ:OKTA) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $100.00 price target on the stock. This represents a 17.5% upside from the current price of $85.11.
Grupo Supervielle (NYSE:SUPV) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “overweight” rating. They now have a $19.00 price target on the stock. This represents a 23.6% upside from the current price of $15.37.
AT&T (NYSE:T) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $28.00 price target on the stock, up previously from $19.00. This represents a 21.2% upside from the current price of $23.11.
Teradyne (NASDAQ:TER) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $158.00 price target on the stock, up previously from $145.00. This represents a 22.2% upside from the current price of $129.32.
Trimble (NASDAQ:TRMB) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $90.00 price target on the stock. This represents a 20.4% upside from the current price of $74.78.
U.S. Physical Therapy (NYSE:USPH) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $115.00 price target on the stock, up previously from $100.00. This represents a 18.6% upside from the current price of $97.00.
Zymeworks (NYSE:ZYME) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $18.00 price target on the stock. This represents a 31.4% upside from the current price of $13.70.
Adient (NYSE:ADNT) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $20.00 price target on the stock, down previously from $27.00. This represents a 8.2% upside from the current price of $18.48.
Alector (NASDAQ:ALEC) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $4.00 price target on the stock. This represents a 102.0% upside from the current price of $1.98.
Amer Sports (NYSE:AS) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating. They now have a $30.00 price target on the stock. This represents a 7.4% upside from the current price of $27.93.
Credicorp (NYSE:BAP) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $208.00 price target on the stock, down previously from $209.00. This represents a 9.4% upside from the current price of $190.18.
Brown-Forman (NYSE:BF.B) was downgraded by analysts at Truist Financial Co. from a “buy” rating to a “hold” rating. They now have a $45.00 price target on the stock, down previously from $50.00. This represents a 1.9% upside from the current price of $44.18.
Biogen (NASDAQ:BIIB) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $175.00 price target on the stock. This represents a 16.5% upside from the current price of $150.25.
TopBuild (NYSE:BLD) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “inline” rating. They now have a $381.00 price target on the stock, down previously from $443.00. This represents a 10.8% upside from the current price of $344.00.
Banco Santander-Chile (NYSE:BSAC) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $21.00 price target on the stock, down previously from $22.00. This represents a 8.0% upside from the current price of $19.44.
Comcast (NASDAQ:CMCSA) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $45.00 price target on the stock, down previously from $48.00. This represents a 13.9% upside from the current price of $39.51.
CNX Resources (NYSE:CNX) was downgraded by analysts at Mizuho from a “neutral” rating to an “underperform” rating. They now have a $38.00 price target on the stock, up previously from $33.00. This represents a 2.3% upside from the current price of $37.15.
Editas Medicine (NASDAQ:EDIT) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating.The current price is $1.54.
Eagle Materials (NYSE:EXP) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $310.00 price target on the stock, down previously from $330.00. This represents a 13.6% upside from the current price of $272.96.
Ford Motor (NYSE:F) was downgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to an “underperform” rating. They now have a $9.00 price target on the stock, down previously from $12.00. This represents a 10.6% downside from the current price of $10.07.
Installed Building Products (NYSE:IBP) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “underperform” rating. They now have a $206.00 price target on the stock, down previously from $238.00. This represents a 3.3% upside from the current price of $199.47.
Keros Therapeutics (NASDAQ:KROS) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.The current price is $19.14.
Logitech International (NASDAQ:LOGI) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $92.00 price target on the stock, down previously from $114.00. This represents a 12.5% upside from the current price of $81.80.
Masco (NYSE:MAS) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $89.00 price target on the stock, down previously from $96.00. This represents a 13.3% upside from the current price of $78.54.
Microchip Technology (NASDAQ:MCHP) was downgraded by analysts at Bank of America Co. from a “neutral” rating to an “underperform” rating. They now have a $65.00 price target on the stock, down previously from $80.00. This represents a 9.6% upside from the current price of $59.32.
MongoDB (NASDAQ:MDB) was downgraded by analysts at Monness Crespi & Hardt from a “neutral” rating to a “sell” rating. They now have a $220.00 price target on the stock. This represents a 18.0% downside from the current price of $268.24.
Match Group (NASDAQ:MTCH) was downgraded by analysts at New Street Research from a “buy” rating to a “neutral” rating.The current price is $33.00.
Netflix (NASDAQ:NFLX) was downgraded by analysts at Loop Capital from a “buy” rating to a “hold” rating. They now have a $950.00 price target on the stock, up previously from $800.00. This represents a 2.9% upside from the current price of $922.79.
Northern Oil and Gas (NYSE:NOG) was downgraded by analysts at Mizuho from an “outperform” rating to a “neutral” rating. They now have a $47.00 price target on the stock. This represents a 17.5% upside from the current price of $39.99.
Par Pacific (NYSE:PARR) was downgraded by analysts at Mizuho from an “outperform” rating to a “neutral” rating. They now have a $22.00 price target on the stock, down previously from $26.00. This represents a 38.4% upside from the current price of $15.90.
PBF Energy (NYSE:PBF) was downgraded by analysts at Mizuho from a “neutral” rating to an “underperform” rating. They now have a $31.00 price target on the stock, down previously from $33.00. This represents a 10.3% upside from the current price of $28.11.
Robert Half (NYSE:RHI) was downgraded by analysts at BNP Paribas from an “outperform” rating to an “underperform” rating. They now have a $64.00 price target on the stock. This represents a 15.0% downside from the current price of $75.31.
Suncor Energy (NYSE:SU) (TSE:SU) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating.The current price is $36.10.
Summit Materials (NYSE:SUM) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $52.50 price target on the stock, down previously from $58.00. This represents a 3.3% upside from the current price of $50.80.
Tenet Healthcare (NYSE:THC) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $140.00 price target on the stock, down previously from $196.00. This represents a 2.3% upside from the current price of $136.82.
Universal Health Services (NYSE:UHS) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $198.00 price target on the stock, down previously from $228.00. This represents a 5.8% upside from the current price of $187.21.
Addus HomeCare (NASDAQ:ADUS) is now covered by analysts at JMP Securities. They set an “outperform” rating and a $150.00 price target on the stock. This represents a 15.7% upside from the current price of $129.64.
agilon health (NYSE:AGL) is now covered by analysts at Macquarie. They set a “neutral” rating and a $3.00 price target on the stock. This represents a 30.4% upside from the current price of $2.30.
a.k.a. Brands (NYSE:AKA) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $30.00 price target on the stock. This represents a 42.9% upside from the current price of $21.00.
Akamai Technologies (NASDAQ:AKAM) is now covered by analysts at UBS Group AG. They set a “neutral” rating and a $110.00 price target on the stock. This represents a 10.3% upside from the current price of $99.77.
Benitec Biopharma (NASDAQ:BNTC) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $28.00 price target on the stock. This represents a 133.1% upside from the current price of $12.01.
biote (NASDAQ:BTMD) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $12.00 price target on the stock. This represents a 81.3% upside from the current price of $6.62.
Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $167.00 price target on the stock. This represents a 14.9% upside from the current price of $145.30.
Caledonia Mining (NYSEAMERICAN:CMCL) is now covered by analysts at Maxim Group. They set a “buy” rating and a $17.00 price target on the stock. This represents a 65.4% upside from the current price of $10.28.
ConocoPhillips (NYSE:COP) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $128.00 price target on the stock. This represents a 26.7% upside from the current price of $101.00.
Golden Entertainment (NASDAQ:GDEN) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $38.00 price target on the stock. This represents a 13.9% upside from the current price of $33.37.
Grindr (NYSE:GRND) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $20.00 price target on the stock. This represents a 17.9% upside from the current price of $16.97.
Healthcare Services Group (NASDAQ:HCSG) is now covered by analysts at Macquarie. They set a “neutral” rating and a $13.00 price target on the stock. This represents a 7.3% upside from the current price of $12.12.
Monarch Casino & Resort (NASDAQ:MCRI) is now covered by analysts at Wells Fargo & Company. They set an “underweight” rating and a $79.00 price target on the stock. This represents a 7.3% downside from the current price of $85.18.
Pediatrix Medical Group (NYSE:MD) is now covered by analysts at Macquarie. They set an “outperform” rating and a $18.00 price target on the stock. This represents a 25.5% upside from the current price of $14.34.
Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Macquarie. They set an “outperform” rating and a $25.00 price target on the stock. This represents a 17.3% upside from the current price of $21.31.
Surgery Partners (NASDAQ:SGRY) is now covered by analysts at Bank of America Co.. They set a “buy” rating and a $30.00 price target on the stock. This represents a 43.5% upside from the current price of $20.91.
U.S. Physical Therapy (NYSE:USPH) is now covered by analysts at JMP Securities. They set an “outperform” rating and a $113.00 price target on the stock. This represents a 16.5% upside from the current price of $97.00.
Vishay Intertechnology (NYSE:VSH) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $19.00 price target on the stock. This represents a 2.5% upside from the current price of $18.53.
Waldencast (NASDAQ:WALD) is now covered by analysts at TD Cowen. They set a “hold” rating and a $4.30 price target on the stock. This represents a 7.8% upside from the current price of $3.99.
ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $30.00 price target on the stock. This represents a 236.3% upside from the current price of $8.92.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Apple Inc. (AAPL)
Amazon.com, Inc. (AMZN)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
Microsoft Co. (MSFT)
